Published Articles
List of published articles
-
Published online: 2026-10-22
Long-Term Safety and Clinical Outcomes of Motugivatrep (SJP-0132) 0.3% Ophthalmic Suspension in Patients with Dry Eye Disease: An Open-Label, Phase 3 Study
Source: Clinical Ophthalmology DOI: https://doi.org/10.2147/OPTH.S626385
-
Published online: 2026-09-26
Motugivatrep (SJP-0132) 0.3% Ophthalmic Suspension for Dry Eye Disease: A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 3 Trial
Source: Clinical Ophthalmology DOI: https://doi.org/10.2147/OPTH.S615529
-
Published online: 2026-02-28
遠隔転移を有しない去勢抵抗性前立腺癌（nmCRPC） 患者を対象としたダロルタミドの観察研究（DAROL）： 第3 回中間解析における日本人サブグループ解析 Prespecified third interim analysis of the Darolutamide Observational study（DAROL）in patients with nonmetastatic castration-resistant prostate cancer（nmCRPC）： A Japanese subgroup analysis
Source: 泌尿器外科 DOI: https://igakutosho.co.jp/collections/magazine-urinary/products/zh_3902
-
Published online: 2025-11-30
遠隔転移を有する前立腺癌におけるダロルタミド， ドセタキセルおよびアンドロゲン遮断療法の3剤併用療法： DADOX（製造販売後調査）中間解析結果 Triplet therapy with darolutamide, docetaxel and androgen deprivation therapy in metastatic prostate cancer：an interim analysis results of the DADOX study （post marketing surveillance）
Source: 泌尿器外科 DOI: https://igakutosho.co.jp/collections/magazine-urinary/products/zh_3811
